FBP1 and nonpapillary renal cell carcinoma: The depletion of a gluconeogenic enzyme—fructose-1,6-bisphosphatase 1 (FBP1)—promoted cell proliferation and glycolysis, associating with worse prognosis of ccRCC patients (16).